• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

After FDA approval, Alkermes plans soft launch for antipsychotic Lybalvi

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 03, 2021 at 10:52: AM
via The FDA approval of Alkermes’ new antipsychotic drug Lybalvi couldn’t have gone any better for the company, but it could still face a big challenge positioning the new drug in the highly genericised market.

article source
 

<



Similar threads

cafead
Biogen, Alkermes win FDA approval of Tecfidera successor — but can they actually sell it?
Replies
0
Views
169
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Novartis heaps pressure on Lilly with broad FDA approval for Kisqali in early breast cancer
Replies
0
Views
15
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Apple Watch sleep apnea detection gets FDA approval
Replies
0
Views
14
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Intercept&#039;s liver med Ocaliva takes heat at FDA expert meeting, as hopes for full approval dim
Replies
0
Views
14
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
3 FDA approval dates to watch in the year’s final push
Replies
0
Views
4
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote